European Journal of Hospital Pharmacy : Science and Practice
Overview
European Journal of Hospital Pharmacy : Science and Practice is a scientific journal, published by BMJ Publishing Group since 2012 in English. The journal's country of origin is United Kingdom and its primary focus area is pharmacy.
Details
Details
Abbr.
Eur J Hosp Pharm
Publisher
BMJ Publishing Group
Start
2012
End
Continuing
Frequency
Bimonthly
p-ISSN
2047-9956
e-ISSN
2047-9964
Country
United Kingdom
Language
English
Specialty
Pharmacy
Metrics
Metrics
h-index / Ranks: 11552
24
SJR / Ranks: 10993
360
CiteScore / Ranks: 8368
3.10
JIF / Ranks: 5746
1.7
Recent Articles
11.
Wilkes S, Kalfsvel L, van Rosse F, Versmissen J, van der Kuy H, Zaal R
Eur J Hosp Pharm
. 2025 Feb;
PMID: 39929710
Objectives: Specialised hospital pharmacists, integrated in medical teams on the ward, can improve medication safety. When a specialised hospital pharmacist is temporarily not available, the pharmaceutical care will be conducted...
12.
Tsui L, Wang D, Fan C, Huang Y, Zhang Z, Fang Z, et al.
Eur J Hosp Pharm
. 2025 Feb;
PMID: 39922684
Objectives: This study addressed the gaps in the disclosure of statin-associated adverse drug reactions (ADRs) in China's official database and the inadequacy of cases reported relative to the population size...
13.
Cachafeiro Pin A, Grandio Leivas L, Carames Masana F, Folgar Torres A, Naranjo Sanchez M
Eur J Hosp Pharm
. 2025 Feb;
PMID: 39915050
No abstract available.
14.
Merono Saura M, Garcia Coronel M, Rentero-Redondo L, Urbieta-Sanz E
Eur J Hosp Pharm
. 2025 Feb;
PMID: 39915049
Cytomegalovirus (CMV) is a common herpesvirus that can cause severe infections in immunocompromised patients. Standard treatments, such as ganciclovir and valganciclovir, are usually effective, but refractory CMV requires alternatives like...
15.
Extravasation of enfortumab vedotin: a case report and literature review on antibody-drug conjugates
Pipitone S, Vitale M, Baldessari C, Sabbatini R, Dominici M, Porretta Serapiglia C, et al.
Eur J Hosp Pharm
. 2025 Feb;
PMID: 39904594
Enfortumab vedotin (EV) is an antibody-drug conjugate (ADC) indicated for advanced or metastatic urothelial carcinoma. We describe a case of EV extravasation in a patient with metastatic bladder cancer. The...
16.
Ruiz-Ramos J, Plaza-Diaz A, Puig-Campmany M, Sampol-Mayol C, Blazquez-Andion M, Serrano-Garcia-Calvo A, et al.
Eur J Hosp Pharm
. 2025 Feb;
PMID: 39904593
Objective: Drug-related problems (DRPs) are a frequent reason for visits to the emergency department (ED). However, data about the characteristics associated with early revisits are limited. We aimed to identify...
17.
Billotte J, Ramambason C, Marquet D, Foucault-Fruchard L
Eur J Hosp Pharm
. 2025 Feb;
PMID: 39904592
Objectives: Medication reconciliation (MR) has been identified by the French High Health Authority (HHA) as an advanced criterion for improving the quality of care. Although this activity has been widely...
18.
19.
Riestra A, Urretavizcaya M, Ferro Uriguen A, Olariaga Sarasola O, Iglesias A, Camba Y, et al.
Eur J Hosp Pharm
. 2025 Jan;
PMID: 39890433
Objective: This study aims to evaluate the risk of occupational exposure to hazardous medicinal products (HMPs) when utilising robotic compounding systems for the preparation of antineoplastic sterile medications. Specifically, it...
20.
Misa-Garcia A, Ferro-Rodriguez S, Haro-Martin L, Cavero-Redondo I
Eur J Hosp Pharm
. 2025 Jan;
PMID: 39890432
Background: Immune-mediated inflammatory diseases (IMIDs) are a group of disorders characterised by acute or chronic inflammation. Adalimumab and infliximab are the cornerstones of their pharmacotherapy. This study aimed to determine...